Back
ESC2025 Premium Access

Immunoglobulin G N-glycosylation as a novel biomarker for premature myocardial infarction: a case-control study

Session: Cardiovascular risk assessment: biomarkers (3)
Topic: Biomarkers
Speaker: Doctor M. Ammar (Boston, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mohammed Ammar

Harvard Medical School, Boston (United States of America)
0 follower

3 more presentations in this session

Machine learning-based identification of a proteomics panel for predicting cardiovascular outcomes in the community

Speaker: Mr E. Santana (Leuven, BE)

Access
Abstract
Slides
Video
Like
Thumbnail

Association of CCL17 with risk of major adverse cardiovascular events: a prospective cohort study

Speaker: Mr Z. Wang (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Cystatin C predicts mortality in patients with coronary artery disease both among subjects with and among those without the metabolic syndrome

Speaker: Doctor A. Mader (Feldkirch, AT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiovascular risk assessment: biomarkers (3)

Speakers: Doctor M. Ammar, Mr E. Santana, Mr Z. Wang, Doctor A. Mader
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources